Medicare AdvantageAdministrativeLow impact
[New York] Enhancing care for peri- and postmenopausal women: addressing recurrent UTIs with vaginal estrogen therapy
Anthem BCBS·NY · Urology, OB-GYN, Family Medicine +2 more·Provider Bulletin
Effective date
Aug 1, 2026
We identified it
Aug 2, 2026
Summary
Anthem Blue Cross and Blue Shield (Medicare Advantage) is issuing an education and training bulletin encouraging providers to identify peri- and postmenopausal women with recurrent UTIs and discuss vaginal estrogen therapy as a prevention strategy per AUA guidelines. This is an informational policy promoting clinical best practices, not a billing or coverage rule change.
Action Required
No billing system changes required. This is an educational bulletin, not a coverage, prior authorization, or billing code change. Providers and clinical staff should review the policy and referenced AUA/ACOG resources to familiarize themselves with vaginal estrogen therapy as a treatment option for eligible patients. No documentation, coding, or reimbursement modifications are mandated by this bulletin.